Currencies38131
Market Cap$ 2.26T-0.49%
24h Spot Volume$ 18.94B-21.4%
DominanceBTC56.40%0%ETH9.56%+0.55%
ETH Gas0.08 Gwei
Cryptorank
/

2 Hot Picks for Monday in the US Stock Market


2 Hot Picks for Monday in the US Stock Market

Share:

Predictions Markets

See what traders are focused on

View analytics →
Prediction Banner

The US stock market closed Friday’s bell in the red as leading equities experienced a correction in the charts. The Dow Jones Industrial Average dipped by 305 points while Nasdaq Composite fell by 427 points. In addition, the S&P 500 index slipped 79 points making the overall markets trade in the red.

Also Read: Tesla: TSLA Surges 5% As Trump-Musk Duo Fuels EV Optimism

The stock market snapped its 10-day winning streak in the indices fueled by Trump’s victory in the US election. A brief sell-off was initiated by investors who made quick returns in the last two weeks. The broader market is still brimming with optimism as investors believe Trump’s second term could benefit the economy. In this article, we will highlight two hot stocks to watch out for on Monday during the opening bell.

Also Read: Nvidia Reports Q3 Earnings This Week: Will NVDA Stock Boom Continue?

US Stock Market: 2 Hot Picks For Monday

1. Domino’s Pizza Inc (NYSE: DPZ)

    Source: Getty Images

    Ace investor Warren Buffett has taken an entry position into Domino’s Pizza, Berkshire Hathaway’s latest 13F filing reveals. The investment arm has accumulated 1.28 million shares of Domino’s Pizza worth a whopping $557 million. Domino’s Pizza is on the lower end of the barrel in the US stock market and could surge on Monday after the filing was made public. DPZ is mostly trading sideways and is consolidating in the charts this month. When it picks up steam, it can go from $430 to a high of $475 next.

    Also Read: Meta: Can META Stock Carry Its 50% Surge into 2025?

    2. Vertex Pharmaceuticals Inc (NASDAQ: VRTX)

      Source: Shutterstock

      Vertex Pharmaceuticals stock is currently hovering around the $465 mark in the US stock market. The firm is the only approved therapy to treat the underlying cause of cystic fibrosis (CF), a rare genetic disease. The pharmaceutical firm is projected to generate a revenue of around $10.8 billion this year. Therefore, the stock has more chances of an upside run when the yearly earnings are published. Taking an entry position now could prove beneficial as it’s nearly 50% down from its 52-week high.

      Read the article at Watcher.Guru

      In This News

      Coins

      $ 0.0000824

      $ 0.00344

      $ 0.00214

      $ 0.00132

      $ 0.00338


      Predictions Markets

      See what traders are focused on

      View analytics →
      Prediction Banner

      Share:

      In This News

      Coins

      $ 0.0000824

      $ 0.00344

      $ 0.00214

      $ 0.00132

      $ 0.00338


      Predictions Markets

      See what traders are focused on

      View analytics →
      Prediction Banner

      Share:

      Read More

      Tesla Stock Chart Pattern Points to $759 — a 92% Move From Here

      Tesla Stock Chart Pattern Points to $759 — a 92% Move From Here

      In Brief Tesla stock trades near $394 as two bullish chart patterns near completion....
      Circle Stock Climbs 15% in Pre-Market After Final OCC Approval

      Circle Stock Climbs 15% in Pre-Market After Final OCC Approval

      In Brief Circle stock climbed nearly 15% in pre-market after winning final OCC appro...